Abstract:Abstract Protocadherin-19 ( PCDH19 ) pathogenic variants cause an early-onset seizure disorder called girls clustering epilepsy (GCE). GCE is an X-chromosome disorder that affects heterozygous females and mosaic males, however hemizygous (“transmitting”) males are spared. We aimed to define the neuropsychiatric profile associated with PCDH19 pathogenic variants and determine if a clinical profile exists for transmitting males. We also examined genotype- and phenotype–phenotype associations. We developed an online PCDH19 survey comprising the following standardized assessments: The Behavior Rating Inventory of Executive Function; the Social Responsiveness Scale, 2nd edition; the Strengths and Difficulties Questionnaire; and the Dimensional Obsessive-Compulsive Scale. Genetic, seizure, and developmental information were also collected. The survey was completed by patients or by caregivers on behalf of patients. Of the 112 individuals represented (15 males), there were 70 unique variants. Thirty-five variants were novel and included a newly identified recurrent variant Ile781Asnfs*3. There were no significant differences in phenotypic outcomes between published and unpublished cases. Seizures occurred in clusters in 94% of individuals, with seizures resolving in 28% at an average age of 17.5 years. Developmental delay prior to seizure onset occurred in 18% of our cohort. Executive dysfunction and autism spectrum disorder (ASD) occurred in approximately 60% of individuals. The ASD profile included features of attention-deficit hyperactivity disorder. In addition, 21% of individuals met criteria for obsessive-compulsive disorder that appeared to be distinct from ASD. There were no phenotypic differences between heterozygous females and mosaic males. We describe a mosaic male and two hemizygous males with atypical clinical profiles. Earlier seizure onset age and increased number of seizures within a cluster were associated with more severe ASD symptoms ( p = 0.001), with seizure onset also predictive of executive dysfunction ( p = 4.69 × 10 −4 ) and prosocial behavior ( p = 0.040). No clinical profile was observed for transmitting males. This is the first patient-derived standardized assessment of the neuropsychiatric profile of GCE. These phenotypic insights will inform diagnosis, management, and prognostic and genetic counseling.

Investigations of an individual with a Marfanoid habitus, mild intellectual disability, and severe social anxiety identifies PCDHGA5 as a candidate neurodevelopmental disorder gene

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

Further delineation of the rare GDACCF (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies syndrome): genotype and phenotype of 22 patients with ZNF148 mutations

Biallelic Variants in PCDHGC4 Cause a Novel Neurodevelopmental Syndrome with Progressive Microcephaly, Seizures, and Joint Anomalies.

Genetic of preimplantation diagnosis of dysmorphic facial features and intellectual developmental disorder (CHDFIDD) without congenital heart defects

A standardized patient-centered characterization of the phenotypic spectrum of PCDH19 girls clustering epilepsy

Identification of Novel Mutations Confirms Pde4d as a Major Gene Causing Acrodysostosis

Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities

The Otto Aufranc Award: Identification of a 4 Mb region on chromosome 17q21 linked to developmental dysplasia of the hip in one 18-member, multigeneration family

Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3

Identification and characterization of a new variation in DPM2 gene in two Chinese siblings with mild intellectual impairment

Multiple molecular diagnoses in the field of intellectual disability and congenital anomalies: 3.5% of all positive cases

Extended phenotypic characterization of a novel Helsmoortel‐van der Aa syndrome case series

Neurological abnormalities in individuals with Marfan syndrome: results from a genetically confirmed Italian cohort

A Long-Term Follow-Up of a Patient with a Novel PORCN Variant and Additional Clinical Features

Association of modifiers and other genetic factors explain Marfan syndrome clinical variability

Epigenomic and phenotypic characterization of DEGCAGS syndrome

Case Report: A Novel Compound Heterozygous Mutation of the FRMD4A Gene Identified in a Chinese Family With Global Developmental Delay, Intellectual Disability, and Ataxia

Morphometric network-based abnormalities correlate with psychiatric comorbidities and gene expression in PCDH19- related developmental and epileptic encephalopathy

Genetic analysis of a novel FBN1 mutation in a pediatric Marfan syndrome patient

X-Linked Intellectual Disability, A Novel KDM5C Variation: A Case Report